{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:10:56Z","timestamp":1790892656922,"version":"4.1.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Domp\u00e9 Farmaceutici Spa"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Optic neuropathy is a major cause of irreversible blindness worldwide, and no effective treatment is currently available. Secondary degeneration is believed to be the major contributor to retinal ganglion cell (RGC) death, the endpoint of optic neuropathy. Partial optic nerve transection (pONT) is an established model of optic neuropathy. Although the mechanisms of primary and secondary degeneration have been delineated in this model, until now how this is influenced by therapy is not well-understood. In this article, we describe a clinically translatable topical, neuroprotective treatment (recombinant human nerve growth factor, rh-NGF) predominantly targeting secondary degeneration in a pONT rat model. Topical application of rh-NGF twice daily for 3 weeks significantly improves RGC survival as shown by reduced RGC apoptosis\n                    <jats:italic>in vivo<\/jats:italic>\n                    and increased RGC population in the inferior retina, which is predominantly affected in this model by secondary degeneration. Topical rh-NGF also promotes greater axonal survival and inhibits astrocyte activity in the optic nerve. Collectively, these results suggest that topical rh-NGF exhibits neuroprotective effects on retinal neurons via influencing secondary degeneration process. As topical rh-NGF is already involved in early clinical trials, this highlights its potential in multiple indications in patients, including those affected by glaucomatous optic neuropathy.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-60427-2","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T06:03:07Z","timestamp":1582610587000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Topical recombinant human Nerve growth factor (rh-NGF) is neuroprotective to retinal ganglion cells by targeting secondary degeneration"],"prefix":"10.1038","volume":"10","author":[{"given":"Li","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivedita","family":"Ravindran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Galvao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neel","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Haamedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehtesham","family":"Shamsher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vy","family":"Luong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Fico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8663-6525","authenticated-orcid":false,"given":"M. Francesca","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,25]]},"reference":[{"key":"60427_CR1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.55782\/ane-2011-1848","volume":"71","author":"CA Oyinbo","year":"2011","unstructured":"Oyinbo, C. A. Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade. Acta Neurobiol. Exp. (Wars). 71, 281\u2013299 (2011).","journal-title":"Acta Neurobiol. Exp. (Wars)."},{"key":"60427_CR2","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1089\/0897715041269641","volume":"21","author":"E Park","year":"2004","unstructured":"Park, E., Velumian, A. A. & Fehlings, M. G. The Role of Excitotoxicity in Secondary Mechanisms of Spinal Cord Injury: A Review with an Emphasis on the Implications for White Matter Degeneration. J. Neurotrauma 21, 754\u2013774 (2004).","journal-title":"J. Neurotrauma"},{"key":"60427_CR3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.expneurol.2014.06.007","volume":"261","author":"RL O\u2019Hare Doig","year":"2014","unstructured":"O\u2019Hare Doig, R. L. et al. Reactive species and oxidative stress in optic nerve vulnerable to secondary degeneration. Exp. Neurol. 261, 136\u2013146 (2014).","journal-title":"Exp. Neurol."},{"key":"60427_CR4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/ana.24099","volume":"75","author":"DP Stirling","year":"2014","unstructured":"Stirling, D. P., Cummins, K., Wayne Chen, S. R. & Stys, P. Axoplasmic reticulum Ca2+ release causes secondary degeneration of spinal axons. Ann. Neurol. 75, 220\u2013229 (2014).","journal-title":"Ann. Neurol."},{"key":"60427_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.bbi.2017.09.006","volume":"67","author":"KA Jones","year":"2018","unstructured":"Jones, K. A. et al. Peripheral immune cells infiltrate into sites of secondary neurodegeneration after ischemic stroke. Brain. Behav. Immun. 67, 299\u2013307 (2018).","journal-title":"Brain. Behav. Immun."},{"key":"60427_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/B978-0-444-59544-7.00012-3","volume":"201","author":"LA Wyatt","year":"2012","unstructured":"Wyatt, L. A. & Keirstead, H. S. Stem cell-based treatments for spinal cord injury. Prog. Brain Res. 201, 233\u201352 (2012).","journal-title":"Prog. Brain Res."},{"key":"60427_CR7","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1167\/iovs.02-0646","volume":"44","author":"H Levkovitch-Verbin","year":"2003","unstructured":"Levkovitch-Verbin, H. et al. A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection. Invest. Ophthalmol. Vis. Sci. 44, 3388\u20133393 (2003).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"60427_CR8","doi-asserted-by":"publisher","first-page":"e50230","DOI":"10.1371\/journal.pone.0050230","volume":"7","author":"G Rizzo","year":"2012","unstructured":"Rizzo, G. et al. Secondary Post-Geniculate Involvement in Leber\u2019s Hereditary Optic Neuropathy. PLoS One 7, e50230 (2012).","journal-title":"PLoS One"},{"key":"60427_CR9","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley, H. A. & Broman, A. T. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 90, 262\u2013267 (2006).","journal-title":"Br. J. Ophthalmol."},{"key":"60427_CR10","first-page":"233","volume":"1","author":"R Behbehani","year":"2007","unstructured":"Behbehani, R. Clinical approach to optic neuropathies. Clin. Ophthalmol. 1, 233\u201346 (2007).","journal-title":"Clin. Ophthalmol."},{"key":"60427_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1515\/revneuro-2013-0003","volume":"24","author":"Y You","year":"2013","unstructured":"You, Y., Gupta, V. K., Li, J. C., Klistorner, A. & Graham, S. L. Optic neuropathies: Characteristic features and mechanisms of retinal ganglion cell loss. Rev. Neurosci. 24, 301\u2013321 (2013).","journal-title":"Rev. Neurosci."},{"key":"60427_CR12","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham, Y. C. et al. Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040. A Systematic Review and Meta-Analysis. Ophthalmology 121, 2081\u20132090 (2014).","journal-title":"Ophthalmology"},{"issue":"6","key":"60427_CR13","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00401-016-1609-2","volume":"132","author":"Benjamin Michael Davis","year":"2016","unstructured":"Davis, B. M., Crawley, L., Pahlitzsch, M., Javaid, F. & Cordeiro, M. F. Glaucoma: the retina and beyond. Acta Neuropathol. 807\u2013826, https:\/\/doi.org\/10.1007\/s00401-016-1609-2 (2016).","journal-title":"Acta Neuropathologica"},{"key":"60427_CR14","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/S0002-9394(02)01403-4","volume":"133","author":"JE Oliver","year":"2002","unstructured":"Oliver, J. E. et al. Blindness and glaucoma: a comparison of patients progressing to blindness from glaucoma with patients maintaining vision. Am. J. Ophthalmol. 133, 764\u2013772 (2002).","journal-title":"Am. J. Ophthalmol."},{"key":"60427_CR15","first-page":"2109","volume":"9","author":"K Tian","year":"2015","unstructured":"Tian, K., Shibata-Germanos, S., Pahlitzsch, M. & Cordeiro, M. F. Current perspective of neuroprotection and glaucoma. Clin. Ophthalmol. 9, 2109\u201318 (2015).","journal-title":"Clin. Ophthalmol."},{"key":"60427_CR16","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.exer.2010.08.009","volume":"91","author":"A Baltmr","year":"2010","unstructured":"Baltmr, A., Duggan, J., Nizari, S., Salt, T. E. & Cordeiro, M. F. Neuroprotection in glaucoma \u2013 Is there a future role? Exp. Eye Res. 91, 554\u2013566 (2010).","journal-title":"Exp. Eye Res."},{"key":"60427_CR17","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/brain\/awx088","volume":"140","author":"MF Cordeiro","year":"2017","unstructured":"Cordeiro, M. F. et al. Real-time imaging of single neuronal cell apoptosis in patients with glaucoma. Brain 140, 1757\u20131767 (2017).","journal-title":"Brain"},{"key":"60427_CR18","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1126\/science.3306916","volume":"237","author":"R Levi-Montalcini","year":"1987","unstructured":"Levi-Montalcini, R. The nerve growth factor 35 years later. Science (80-.). 237, 1154\u20131162 (1987).","journal-title":"Science (80-.)."},{"key":"60427_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.pharmthera.2013.01.004","volume":"138","author":"SJ Allen","year":"2013","unstructured":"Allen, S. J., Watson, J. J., Shoemark, D. K., Barua, N. U. & Patel, N. K. GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol. Ther. 138, 155\u2013175 (2013).","journal-title":"Pharmacol. Ther."},{"key":"60427_CR20","first-page":"759473","volume":"2014","author":"H Wang","year":"2014","unstructured":"Wang, H. et al. The nerve growth factor signaling and its potential as therapeutic target for glaucoma. Biomed. Res. Int. 2014, 759473 (2014).","journal-title":"Biomed. Res. Int."},{"key":"60427_CR21","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/jcp.24573","volume":"229","author":"G Roberti","year":"2014","unstructured":"Roberti, G., Mantelli, F., Macchi, I., Massaro-Giordano, M. & Centofanti, M. Nerve growth factor modulation of retinal ganglion cell physiology. J. Cell. Physiol. 229, 1130\u20131133 (2014).","journal-title":"J. Cell. Physiol."},{"key":"60427_CR22","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/0014-4886(91)90097-V","volume":"111","author":"G1 Carmignoto","year":"1991","unstructured":"Carmignoto, G. 1 et al. M. L. Expression of NGF receptor and NGF receptro mRNA in the developing and adult rat retina. Exp. Neurol. 111, 302\u2013311 (1991).","journal-title":"Exp. Neurol."},{"key":"60427_CR23","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1007\/s00417-008-0913-5","volume":"246","author":"M Coassin","year":"2008","unstructured":"Coassin, M. et al. Retinal p75 and bax overexpression is associated with retinal ganglion cells apoptosis in a rat model of glaucoma. Graefe\u2019s Arch. Clin. Exp. Ophthalmol. 246, 1743\u20131749 (2008).","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"60427_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.neulet.2008.09.024","volume":"446","author":"V Sposato","year":"2008","unstructured":"Sposato, V. et al. Reduced NGF level and TrkA protein and TrkA gene expression in the optic nerve of rats with experimentally induced glaucoma. Neurosci. Lett. 446, 20\u201324 (2008).","journal-title":"Neurosci. Lett."},{"key":"60427_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/IJG.0b013e3181d787e5","volume":"20","author":"V Colafrancesco","year":"2011","unstructured":"Colafrancesco, V. et al. Ocular Application of Nerve Growth Factor Protects Degenerating Retinal Ganglion Cells in a Rat Model of Glaucoma. J. Glaucoma 20, 100\u2013108 (2011).","journal-title":"J. Glaucoma"},{"key":"60427_CR26","doi-asserted-by":"publisher","first-page":"13469","DOI":"10.1073\/pnas.0906678106","volume":"106","author":"A Lambiase","year":"2009","unstructured":"Lambiase, A. et al. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma. Proc. Natl. Acad. Sci. 106, 13469\u201313474 (2009).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"60427_CR27","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1167\/iovs.05-0301","volume":"46","author":"A Lambiase","year":"2005","unstructured":"Lambiase, A., Tirassa, P., Micera, A., Aloe, L. & Bonini, S. Pharmacokinetics of Conjunctivally Applied Nerve Growth Factor in the Retina and Optic Nerve of Adult Rats. Investig. Opthalmology Vis. Sci. 46, 3800 (2005).","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"60427_CR28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.4103\/1673-5374.130093","volume":"9","author":"HY Li","year":"2014","unstructured":"Li, H. Y., Ruan, Y. W., Ren, C. R., Cui, Q. & So, K. F. Mechanisms of secondary degeneration after partial optic nerve transection. Neural Regen. Res. 9, 565\u2013574 (2014).","journal-title":"Neural Regen. Res."},{"key":"60427_CR29","doi-asserted-by":"publisher","first-page":"5456","DOI":"10.1167\/iovs.09-3717","volume":"50","author":"M Fitzgerald","year":"2009","unstructured":"Fitzgerald, M. et al. Secondary retinal ganglion cell death and the neuroprotective effects of the calcium channel blocker lomerizine. Invest. Ophthalmol. Vis. Sci. 50, 5456\u20135462 (2009).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"60427_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.399","volume":"5","author":"L Guo","year":"2014","unstructured":"Guo, L. et al. Direct optic nerve sheath (DONS) application of Schwann cells prolongs retinal ganglion cell survival in vivo. Cell Death Dis. 5, e1460 (2014).","journal-title":"Cell Death Dis."},{"key":"60427_CR31","doi-asserted-by":"publisher","first-page":"16031","DOI":"10.1038\/cddiscovery.2016.31","volume":"2","author":"BM Davis","year":"2016","unstructured":"Davis, B. M. et al. Automatic quantitative analysis of experimental primary and secondary retinal neurodegeneration: implications for optic neuropathies. Cell Death Discov. 2, 16031 (2016).","journal-title":"Cell Death Discov."},{"key":"60427_CR32","doi-asserted-by":"publisher","first-page":"e2270","DOI":"10.1038\/cddis.2016.174","volume":"7","author":"BM Davis","year":"2016","unstructured":"Davis, B. M. et al. Towards maximising information extraction from rodent models of ocular disease. Cell Death Dis. 7, e2270\u2013e2270 (2016).","journal-title":"Cell Death Dis."},{"key":"60427_CR33","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1167\/iovs.08-3267","volume":"50","author":"FM Nadal-Nicol\u00e1s","year":"2009","unstructured":"Nadal-Nicol\u00e1s, F. M. et al. Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas. Invest. Ophthalmol. Vis. Sci. 50, 3860\u20133868 (2009).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"60427_CR34","first-page":"441","volume":"200","author":"H Wassle","year":"1978","unstructured":"Wassle, H. & Riemann, H. J. The Mosaic of Nerve Cells in the Mammalian Retina. Proc. R. Soc. B Biol. Sci. 200, 441\u2013461 (1978).","journal-title":"Proc. R. Soc. B Biol. Sci."},{"key":"60427_CR35","first-page":"620","volume":"7","author":"H Wang","year":"2012","unstructured":"Wang, H. et al. Neurofilament proteins in axonal regeneration and neurodegenerative diseases. Neural Regen. Res. 7, 620\u20136 (2012).","journal-title":"Neural Regen. Res."},{"key":"60427_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0006-8993(79)90916-8","volume":"177","author":"JE Turner","year":"1979","unstructured":"Turner, J. E. & Delaney, R. K. Retianl ganglion cell response to axotomy and nerve growth factor antiserum in the regenerating visual system of the NEWT (notophalmus viridescens): an ultrastructural morphometric analysis. Brain Res. 177, 35\u201347 (1979).","journal-title":"Brain Res."},{"key":"60427_CR37","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1523\/JNEUROSCI.03-11-02172.1983","volume":"3","author":"EMJ H.K. Yip","year":"1983","unstructured":"H.K. Yip, E. M. J. Retrograde transport of nerve growth factor in lesioned goldfish retinal ganglion cells. J. Neurosci. 3, 2172\u20132182 (1983).","journal-title":"J. Neurosci."},{"key":"60427_CR38","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1523\/JNEUROSCI.09-04-01263.1989","volume":"9","author":"G Carmignoto","year":"1989","unstructured":"Carmignoto, G. & Terme, A. Effect of NGF on the Survival of Rat Retinal Ganglion Optic Nerve Section Cells Following. J. Neurosci. 9, 1263\u20131272 (1989).","journal-title":"J. Neurosci."},{"key":"60427_CR39","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/0306-4522(94)90565-7","volume":"63","author":"SA Rabacchi","year":"1994","unstructured":"Rabacchi, S. A., Ensini, M., Bonfanti, L., Gravina, A. & Maffei, L. Nerve growth factor reduces apoptosis of axotomized retinal ganglion cells in the neonatal rat. Neuroscience 63, 969\u2013973 (1994).","journal-title":"Neuroscience"},{"key":"60427_CR40","first-page":"284","volume":"47","author":"V Colafrancesco","year":"2011","unstructured":"Colafrancesco, V., Coassin, M., Rossi, S. & Aloe, L. Effect of eye NGF administration on two animal models of retinal ganglion cells degeneration. Ann. Ist. Super. 47, 284\u2013289 (2011).","journal-title":"Ann. Ist. Super."},{"key":"60427_CR41","doi-asserted-by":"publisher","first-page":"39392","DOI":"10.1074\/jbc.M110.147801","volume":"285","author":"Y Bai","year":"2010","unstructured":"Bai, Y. et al. Chronic and acute models of retinal neurodegeneration TrkA activity are neuroprotective whereas p75NTR activity is neurotoxic through a paracrine mechanism. J. Biol. Chem. 285, 39392\u201339400 (2010).","journal-title":"J. Biol. Chem."},{"key":"60427_CR42","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/BF03401589","volume":"1","author":"HP Hammes","year":"1995","unstructured":"Hammes, H. P., Federoff, H. J. & Brownlee, M. Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes. Mol. Med. 1, 527\u201334 (1995).","journal-title":"Mol. Med."},{"key":"60427_CR43","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/ICU.0b013e328338679a","volume":"21","author":"KM Sampat","year":"2010","unstructured":"Sampat, K. M. & Garg, S. J. Complications of intravitreal injections. Curr. Opin. Ophthalmol. 21, 178\u2013183 (2010).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"60427_CR44","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/ICU.0b013e3283543b61","volume":"23","author":"A Lambiase","year":"2012","unstructured":"Lambiase, A., Sacchetti, M. & Bonini, S. Nerve growth factor therapy for corneal disease. Curr. Opin. Ophthalmol. 23, 296\u2013302 (2012).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"60427_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0750-3","volume":"14","author":"B Falsini","year":"2016","unstructured":"Falsini, B. et al. NGF eye-drops topical administration in patients with retinitis pigmentosa, a pilot study. J. Transl. Med. 14, 8 (2016).","journal-title":"J. Transl. Med."},{"key":"60427_CR46","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s40259-013-0079-5","volume":"28","author":"MP Ferrari","year":"2014","unstructured":"Ferrari, M. P. et al. Safety and Pharmacokinetics of Escalating Doses of Human Recombinant Nerve Growth Factor Eye Drops in a Double-Masked, Randomized Clinical Trial. BioDrugs 28, 275\u2013283 (2014).","journal-title":"BioDrugs"},{"key":"60427_CR47","doi-asserted-by":"publisher","first-page":"294","DOI":"10.2174\/1570159X13666150403231920","volume":"13","author":"L Aloe","year":"2015","unstructured":"Aloe, L., Rocco, M. L., Balzamino, B. O. & Micera, A. Nerve Growth Factor: A Focus on Neuroscience and Therapy. Curr. Neuropharmacol. 13, 294\u2013303 (2015).","journal-title":"Curr. Neuropharmacol."},{"key":"60427_CR48","first-page":"587","volume":"43","author":"J Danias","year":"2002","unstructured":"Danias, J. et al. Cytoarchitecture of the retinal ganglion cells in the rat. Invest. Ophthalmol. Vis. Sci. 43, 587\u2013594 (2002).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"60427_CR49","first-page":"439","volume":"45","author":"A Lambiase","year":"2009","unstructured":"Lambiase, A., Coassin, M., Tirassa, P., Mantelli, F. & Aloe, L. Nerve growth factor eye drops improve visual acuity and electrofunctional activity in age-related macular degeneration: a case report. Ann. Ist. Super. Sanita 45, 439\u201342 (2009).","journal-title":"Ann. Ist. Super. Sanita"},{"key":"60427_CR50","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1177\/1545968310397201","volume":"25","author":"B Falsini","year":"2011","unstructured":"Falsini, B. et al. Topical Nerve Growth Factor as a Visual Rescue Strategy in Pediatric Optic Gliomas. Neurorehabil. Neural Repair 25, 512\u2013520 (2011).","journal-title":"Neurorehabil. Neural Repair"},{"key":"60427_CR51","first-page":"3232","volume":"34","author":"R Siliprandi","year":"1993","unstructured":"Siliprandi, R., Canella, R. & Carmignoto, G. Nerve growth factor promotes functional recovery of retinal ganglion cells after ischemia. Invest. Ophthalmol. Vis. Sci. 34, 3232\u201345 (1993).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"60427_CR52","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1007\/BF02332863","volume":"235","author":"A Lambiase","year":"1997","unstructured":"Lambiase, A. et al. Nerve growth factor (NGF) reduces and NGF antibody exacerbates retinal damage induced in rabbit by experimental ocular hypertension. Graefes Arch. Clin. Exp. Ophthalmol. 235, 780\u20135 (1997).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"60427_CR53","doi-asserted-by":"publisher","first-page":"13898","DOI":"10.1074\/jbc.M209164200","volume":"278","author":"M Salinas","year":"2003","unstructured":"Salinas, M., Diaz, R., Abraham, N. G., Ruiz de Galarreta, C. M. & Cuadrado, A. Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner. J. Biol. Chem. 278, 13898\u2013904 (2003).","journal-title":"J. Biol. Chem."},{"key":"60427_CR54","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/jnr.22784","volume":"90","author":"J Wells","year":"2012","unstructured":"Wells, J. et al. Early in vivo changes in calcium ions, oxidative stress markers, and ion channel immunoreactivity following partial injury to the optic nerve. J. Neurosci. Res. 90, 606\u2013618 (2012).","journal-title":"J. Neurosci. Res."},{"key":"60427_CR55","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1089\/neu.2009.1112","volume":"27","author":"M Fitzgerald","year":"2010","unstructured":"Fitzgerald, M., Bartlett, C. A., Harvey, A. R. & Dunlop, S. A. Early Events of Secondary Degeneration after Partial Optic Nerve Transection: An Immunohistochemical Study. J. Neurotrauma. 27, 439\u2013452 (2010).","journal-title":"J. Neurotrauma."},{"key":"60427_CR56","doi-asserted-by":"publisher","first-page":"26209","DOI":"10.1074\/jbc.274.37.26209","volume":"274","author":"H Jiang","year":"1999","unstructured":"Jiang, H. et al. Nerve growth factor (NGF)-induced calcium influx and intracellular calcium mobilization in 3T3 cells expressing NGF receptors. J. Biol. Chem. 274, 26209\u201326216 (1999).","journal-title":"J. Biol. Chem."},{"key":"60427_CR57","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cellsig.2017.08.006","volume":"40","author":"A Ahluwalia","year":"2017","unstructured":"Ahluwalia, A., Jones, M. K., Hoa, N. & Tarnawski, A. S. NGF protects endothelial cells from indomethacin-induced injury through activation of mitochondria and upregulation of IGF-1. Cell. Signal. 40, 22\u201329 (2017).","journal-title":"Cell. Signal."},{"key":"60427_CR58","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00441-013-1600-3","volume":"353","author":"RM Werkmeister","year":"2013","unstructured":"Werkmeister, R. M., Cherecheanu, A. P., Garhofer, G., Schmidl, D. & Schmetterer, L. Imaging of retinal ganglion cells in glaucoma: pitfalls and challenges. Cell Tissue Res. 353, 261\u2013268 (2013).","journal-title":"Cell Tissue Res."},{"key":"60427_CR59","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.preteyeres.2011.11.002","volume":"31","author":"M Almasieh","year":"2012","unstructured":"Almasieh, M., Wilson, A. M., Morquette, B., Cueva Vargas, J. L. & Di Polo, A. The molecular basis of retinal ganglion cell death in glaucoma. Prog. Retin. Eye Res. 31, 152\u2013181 (2012).","journal-title":"Prog. Retin. Eye Res."},{"key":"60427_CR60","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0079-6123(08)01130-8","volume":"173","author":"L Guo","year":"2008","unstructured":"Guo, L. & Cordeiro, M. F. Assessment of neuroprotection in the retina with DARC. Prog. Brain Res. 173, 437\u201350 (2008).","journal-title":"Prog. Brain Res."},{"key":"60427_CR61","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-1-4939-2152-2_17","volume-title":"Methods in Molecular Biology","author":"Eduardo M. Normando","year":"2014","unstructured":"Normando, E. M. et al. Real-Time Imaging of Retinal Cell Apoptosis by Confocal Scanning Laser Ophthalmoscopy. In Neuronal Cell Death: Methods and Protocols 227\u2013237, https:\/\/doi.org\/10.1007\/978-1-4939-2152-2_17 (2015)."},{"key":"60427_CR62","doi-asserted-by":"publisher","first-page":"13352","DOI":"10.1073\/pnas.0405479101","volume":"101","author":"MF Cordeiro","year":"2004","unstructured":"Cordeiro, M. F. et al. Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration. Proc. Natl. Acad. Sci. 101, 13352\u201313356 (2004).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"60427_CR63","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1167\/iovs.05-0754","volume":"47","author":"L Guo","year":"2006","unstructured":"Guo, L. et al. Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo. Invest. Ophthalmol. Vis. Sci. 47, 626\u2013633 (2006).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"60427_CR64","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1080\/02713680701585872","volume":"32","author":"A Maass","year":"2007","unstructured":"Maass, A. et al. Assessment of rat and mouse RGC apoptosis imaging in vivo with different scanning laser ophthalmoscopes. Curr. Eye Res. 32, 851\u201361 (2007).","journal-title":"Curr. Eye Res."},{"issue":"1","key":"60427_CR65","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1038\/cddis.2009.3","volume":"1","author":"M F Cordeiro","year":"2010","unstructured":"Cordeiro, M. F. et al. Imaging multiple phases of neurodegeneration: a novel approach to assessing cell death in vivo. Cell Death Dis. 1 (2010).","journal-title":"Cell Death & Disease"},{"key":"60427_CR66","doi-asserted-by":"publisher","first-page":"13444","DOI":"10.1073\/pnas.0703707104","volume":"104","author":"L Guo","year":"2007","unstructured":"Guo, L. et al. Targeting amyloid-beta in glaucoma treatment. Proc. Natl. Acad. Sci. USA 104, 13444\u20139 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"60427_CR67","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.mcn.2008.12.005","volume":"40","author":"F Lebrun-Julien","year":"2009","unstructured":"Lebrun-Julien, F., Morquette, B., Douillette, A., Saragovi, H. U. & Di Polo, A. Inhibition of p75NTR in glia potentiates TrkA-mediated survival of injured retinal ganglion cells. Mol. Cell. Neurosci. 40, 410\u2013420 (2009).","journal-title":"Mol. Cell. Neurosci."},{"key":"60427_CR68","first-page":"183","volume":"75","author":"SB Koevary","year":"2004","unstructured":"Koevary, S. B., Lam, V. & Patsiopoulos, G. Pharmacokinetics of insulin uptake by ocular tissues and the role of cerebrospinal fluid in optic nerve insulin accumulation following topical insulin application. Optom. - J. Am. Optom. Assoc. 75, 183\u2013188 (2004).","journal-title":"Optom. - J. Am. Optom. Assoc."},{"key":"60427_CR69","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1167\/iovs.02-0482","volume":"44","author":"K Ishii","year":"2003","unstructured":"Ishii, K. et al. Iganidipine, a New Water-Soluble Ca 2+ Antagonist: Ocular and Periocular Penetration after Instillation. Investig. Opthalmology Vis. Sci. 44, 1169 (2003).","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"60427_CR70","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1023\/A:1026024409826","volume":"27","author":"MA Kapin","year":"2003","unstructured":"Kapin, M. A. et al. Inflammation-mediated retinal edema in the rabbit is inhibited by topical nepafenac. Inflammation 27, 281\u201391 (2003).","journal-title":"Inflammation"},{"key":"60427_CR71","doi-asserted-by":"publisher","first-page":"S210","DOI":"10.1016\/S0039-6257(99)00014-4","volume":"43","author":"WE Sponsel","year":"1999","unstructured":"Sponsel, W. E., Terry, S., Khuu, H. D., Lam, K.-W. & Frenzel, H. Periocular Accumulation of Timolol and Betaxolol in Glaucoma Patients Under Long-term Therapy. Surv. Ophthalmol. 43, S210\u2013S213 (1999).","journal-title":"Surv. Ophthalmol."},{"key":"60427_CR72","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1167\/iovs.12-10109","volume":"54","author":"M Lye-Barthel","year":"2013","unstructured":"Lye-Barthel, M., Sun, D. & Jakobs, T. C. Morphology of astrocytes in a glaucomatous optic nerve. Investig. Ophthalmol. Vis. Sci. 54, 909\u2013917 (2013).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"60427_CR73","doi-asserted-by":"publisher","first-page":"e55683","DOI":"10.1371\/journal.pone.0055683","volume":"8","author":"S Zhang","year":"2013","unstructured":"Zhang, S. et al. Expression and Activation of STAT3 in the Astrocytes of Optic Nerve in a Rat Model of Transient Intraocular Hypertension. PLoS One 8, e55683 (2013).","journal-title":"PLoS One"},{"key":"60427_CR74","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/glia.21242","volume":"60","author":"C Dai","year":"2012","unstructured":"Dai, C. et al. Structural basis of glaucoma: The fortified astrocytes of the optic nerve head are the target of raised intraocular pressure. Glia 60, 13\u201328 (2012).","journal-title":"Glia"},{"key":"60427_CR75","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1350-9462(99)00017-8","volume":"19","author":"MR Hernandez","year":"2000","unstructured":"Hernandez, M. R. The optic nerve head in glaucoma: Role of astrocytes in tissue remodelling. Prog. Retin. Eye Res. 19, 297\u2013321 (2000).","journal-title":"Prog. Retin. Eye Res."},{"key":"60427_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.06.003","volume":"51","author":"E Vecino","year":"2015","unstructured":"Vecino, E., Rodriguez, F. D., Ruzafa, N., Pereiro, X. & Sharma, S. C. Glia e neuron interactions in the mammalian retina. Prog. Retin. Eye Res. 51, 1\u201339 (2015).","journal-title":"Prog. Retin. Eye Res."},{"key":"60427_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1755-8794-2-24","volume":"2","author":"T Nikolskaya","year":"2009","unstructured":"Nikolskaya, T. et al. Network analysis of human glaucomatous optic nerve head astrocytes. BMC Med. Genomics 2, 1\u201326 (2009).","journal-title":"BMC Med. Genomics"},{"key":"60427_CR78","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/cne.21279","volume":"878","author":"P Sobrado-calvo","year":"2007","unstructured":"Sobrado-calvo, P. & Vidal-sanz, M. Rat Retinal Microglial Cells Under Normal Conditions, After Optic Nerve Section, and After Optic Nerve Section and Intravitreal Injection of Trophic Factors or Macrophage Inhibitory Factor. J. Comp. Neurol. 878, 866\u2013878 (2007).","journal-title":"J. Comp. Neurol."},{"key":"60427_CR79","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.mcn.2008.12.005","volume":"40","author":"F Lebrun-julien","year":"2009","unstructured":"Lebrun-julien, F., Morquette, B., Douillette, A., Saragovi, H. U. & Di, A. Inhibition of p75 NTR in glia potentiates TrkA-mediated survival of injured retinal ganglion cells. Mol. Cell. Neurosci. 40, 410\u2013420 (2009).","journal-title":"Mol. Cell. Neurosci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60427-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60427-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60427-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T22:24:33Z","timestamp":1722464673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60427-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,25]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["60427"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-60427-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,25]]},"assertion":[{"value":"27 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Professor M. Francesca Cordeiro is a named inventor on a patent application covering the DARC technology disclosed in this manuscript. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3375"}}